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Application of Informed Consent
Principles in the Emergency Department
Evaluation of Febrile Children at Risk for
Occult Bacteremia
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Informed consent requires that the risks and benefits of a particular
diagnostic and therapeutic plan be reviewed with the patient,
including the disclosure of alternative diagnostic and treatment
approaches. Although it could be argued that it is difficult to present
all the diagnostic and therapeutic options to parents in the E. D.
management of febrile children at risk for occult bacteremia, it is the
purpose of this report to describe the experience with following
these principles of informed consent in a group of these children.
Methods: Convenience sample of febrile children presenting to
an E.D. at risk for occult bacteremia. A standardized information
sheet was presented. A parent survey of preferences followed.
Results: In 37 patients, most of the parents chose no tests and
preferred to be involved in the medical decision making process for
their child.
Conclusions: While preferred by parents and supported by AAP,
the process of informed consent, for febrile children at risk for
occult bacteremia, is time consuming and often not possible when
the E.D. is busy. Physicians may find it desirable to make decisions
from an informed consent perspective to a comfort level dependent
on time availability, parents’ comprehension ability, and individual
personal practice preference.
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Introduction
While the authority to make medical decisions used to rest solely
with the physician (doctor knows best theory), this is now consid
ered to be unacceptable.’ In addition to sources in the medical
literature26 and court conclusions,6 the American Academy of
Pediatrics (AAP)’ and the Joint Commission on Accreditation of
Healthcare Organizations (JCAHO)7 have confirmed support of
informed consent, which requires that the risks and benefits of a
particular diagnostic and therapeutic plan be reviewed with the
patient. This review should include the disclosure of alternative
diagnostic and treatment approaches.’-7Decision-making power or
authority is increasingly seen as something to be shared by equal
partners in the physician-patient or physician-parent relationship.’
While reports in the literature have indicated that this is the proper
approach to take, such a practice is time consuming.
In the evaluation of the febrile child at risk for occult bacteremia,
sources in the literature have recommended divergent diagnostic
and therapeutic approaches (Table l).819 According to informed
consent principles, the management of such cases should include
the disclosure of all these approaches.’-7
While physicians may assume that patients generally want more
tests and more treatment in order to avoid as much risk as possible,
a published survey of parents showed that parents often preferred
the opposite of this (fewer tests, less treatment, more risk) in a
hypothetical case scenario involving a 6-week old febrile infant.20
This indicates that when a range of diagnostic and treatment options
are presented to parents, they may often choose the less aggressive
choice even if it involves more risk. This also indicates that true
informed consent with full disclosure of alternatives, is often not
practiced as a standard in this clinical scenario. Although it could be
argued that it is difficult to present all the diagnostic and therapeutic
options involved to parents, it is the purpose of this report to describe
the experience with following the principles of informed consent in
a group of actual children presenting to an E.D. with fever at risk for
occult bacteremia. Quality of care maybe improved by understand
ing this process better to determine ways ofoptimizing the informed
consent process.
Background
The emergency department evaluation of young febrile children
(3 months to 3 years of age) at risk for occult bacteremia is a
recognized controversy. Actual patient data supporting a single
standardized diagnostic evaluation and treatment approach is lack-
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Table 1.—Some recent recommendations in the literature for children at
risk of bacteremia.
Baraff (1993, expert panel practice guidelines)8’9
CBC if temperature 39C. If WBC>15,000, obtain a blood culture and treat
with ceftriaxone. Obtain urine cultures in all males under 6 months and all
females under 2 years who are treated with antibiotics. Less preferred
option is to obtain a blood culture and treat all children with temperature>
39C with empiric antibiotics.
Baraft (1993, review article)10
Same recommendations as above.
Baraff (1992, management guidelines)11
Blood culture and empiric antibiotics. CBC is not recommended.
Bass (1993, 519 patients)12
WCB 15,000 and fever 39.5 C identify children at high risk and should
be treated with antibiotics (amoxicillin/clavulinate orceftriaxone). Routine
treatment of others does not appear to be indicated.
Downs (1991, decision analysis)13
Blood culture and empiric antibiotics for all those at risk (2-4 months and
rectal temperature > 39 C).
Fleisher (1994, 6680 patients)14
If empiric antibiotics are given, ceftriaxone provides a safe and effective
alternative (better outcome profile compared to amoxicillin, however, not
statistically significant).
Jaffe (1994, review articel)10
CBC. Blood culture and empiric antibiotics if WBC > 10,000 or WBC >
15,000/
Kramer (1989, decision analysis)16
No blood culture strategy has the greatest utility.
Lieu (1991, decision analysis)17
Blood culture and empiric antibiotics.
Long (1994, editor’s column)18
No tests, no antibiotics as the preferred choice.
Singer (1995, review article)19
3-6 months: Urinalysis. Parenteral ceftriaxone is not effective. No blood
work unless temperature exceeds 41 C.
6-24 months: CBC and blood cultures it temperature 40 C. Treat with
parenteral antibiotics if WBC 15,000.
ing. Most of the controversy stems from a subjective sense of risk
tolerance. Most studies and reports in the literature on this topic
have identified the children at risk for occult bacteremia as those
from 3 months to 36 months of age with a fever (most commonly
defined as greater than or equal to 39 degrees Celsius).8’9137
Reports which focus on avoiding risk (risk averse) have recom
mended blood cultures and parenteral antibiotics for most or all
children at risk of bacteremia.’3”7Other reports which accept
prudent risk have recommended observation.’8Other reports have
recommended that white blood counts be used to assist in the
decision to administer antibiotics.8’925If antibiotics are to be
administered, the decision of parenteral or oral antibiotics must be
made on similar risk tolerance
While practice guidelines for the evaluation and treatment of these
children have been published in the journals Pediatrics and Annals
ofEmergency Medicine,8’9published surveys of pediatricians dem
onstrate that there is substantial diversity in the management of
these children and many pediatricians do not follow the recommen
dations in the published guidelines.23’4It is NOT the purpose of this
report to examine the superiority of one strategy over another.
Methods
A single page information sheet was drafted explaining bacter
emia, urinary tract infection, meningits, and pneumonia (see appen
dix A). Children were evaluated in the emergency department by the
author (single investigator) during a normal shift schedule in a
pediatric E.D. Parents were given this information sheet if all of the
following criteria were met:
a. Age 3 to 36 months.
b. Temperature> 38.9 degrees C (102 degrees F) in the E.D. or
by reliable history.8
c. No hard indications to perform tests or administer parenteral
antibiotics.
d. Child is active, alert, not toxic, not irritable.
f. No specific physical examination signs of meningitis, urinary
tract infection, pneumonia, or sepsis. Specifically, the following
were documented: anterior fontanelle (ifpresent) flat, neck supple,
not fussy when bounced, no costovertebral angle tenderness evi
dent, lungs clear to auscultation, no tachypnea, not coughing much,
oxygen saturation in room air 98% or higher, no petechia, normal
color, and normal perfusion. Patients were excluded if more than
two episodes of diarrhea (per day) were present. Otitis media was
not a basis for exclusion.
g. The physician had enough time (15 minutes minimum) to
thoroughly review the information sheet with the parents (i.e., low
E.D. patient census at the time).
The information sheet was reviewed with the parent(s) verbally.
Following this lengthy verbal explanation, parents were given the
information sheet to review on their own. All their questions were
answered. All parents claimed that they understood the form. They
were encouraged to ask more questions following all explanations.
A Tests and Treatment Selection sheet (see appendix B) was
verbally reviewed with parents. The treating physician made a
recommendation for laboratory work and antibiotics. It was made
clear to patients that a different physician may justifiably make a
totally different recommendation. It was made clear that the
physician’s recommendation is not necessarily what their private
physician would do. It was made clear that they would not be
offending the physician if they did not follow the physician’s
recommendation. Parents were then asked about their preferences
on the diagnostic tests to be performed and the treatment. Parents
were given the option of not deciding (i.e., accepting the physician’s
recommendation). Once parents made a decision, the advantages
and disadvantages of their decision were again reviewed with them
to be certain that they understood the risk level involved in their
choice.
Clinical and demographic information were collected on these
patients. Parent choices were stratified by demographics. There is
no control group involved. Presumably, a control group would be
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one in which parents had no control in any of the clinical decisions.
Such a control group would be highly biased by the treatment that
is imposed upon them by their physician. Thus, the statistics are
presented as descriptive only (no inferential statistics).
Antipyretics were administered to all patients (either at home or
in the E.D.). Temperatures were rechecked in most patients before
discharge.
This study was presented to the medical center’s institutional
research board (IRB) for review. IRB approval was obtained.
Results
The results of 37 E.D. patients are summarized in tables 2 and 3.
Ages ranged from 3.5 to 35.6 months of age (mean 14.4 months,
standard deviation 9.4). Parents accompanying children ranged in
age from 17 to 42 years of age (mean 28, standard deviation 7). In
instances when both parents accompanied the child to the E.D., the
age of the “dominant parent” was used as the parent’s age for that
child (tables 2 and 3). The dominant parent was the one who
appeared to be making most of the decisions. Of the 37 patients,
mothers were present alone in 21 cases, fathers were present alone
in 2 cases, and both parents were present in 14 cases. Of the 14 cases
when both parents were present, the mother was assessed as being
the dominant parent in 6 cases and the father in 8 cases.
Maximum temperatures ranged from 38.9 to 41.1 degrees C
(mean 39.8, SD 0.5). Otitis media with effusion was diagnosed in 22
of the 37 patients. Five of the 37 patients presented with febrile
seizures. Only one of the 37 patients was on antibiotics prior to the
E.D. visit.
Table 2 stratifies the parental diagnostic test preferences by
demographic and clinical variables. In 2 of the 37 cases, parents did
not want to make a choice. In these two instances, no diagnostic tests
were performed. In 31 of 37 cases, the physician made no recom
mendation on whether to do any tests. In 25 of these 31 instances,
parents chose to do no tests. The physician recommended “no tests”
in three cases. Urine studies only were recommended in one case (17
month old female with fever and vomiting), however, parents
elected for no tests in this instance. A CBC and blood culture were
recommended in one case (24 month old with a febrile seizure in
whom the child’s primary care physician requested the tests). A
complete sepsis work up was recommended in one case (a 3.5 month
old). Parents concurred in these two cases.
When a diagnostic test recommendation was made by the physi
cian (6 instances), parents agreed with this recommendation in four
instances. In one case, urine studies were recommended and the
parent declined this. In one case, the parent declined to make a
choice and the physician’s recommendation was carried out. Thus,
in no instance, did parents request more tests than that recom
mended by the physician.
Of the 31 cases where the physician did not make a diagnostic test
recommendation, there were four cases where parents requested
tests. One case was a 17-month old whose parents requested a chest
radiograph. In two cases, parents (of an 11-month old and a 3.5-
month old) requested a CBC and blood culture. The last case was 24-
month old with a febrile seizure whose parents requested a complete
sepsis work-up.
Parental diagnostic test preferences did not differ significantly by
any of the variables tabulated in table 2. However, the numbers here
Table 2.—Parental diagnostic study preferences (these tests were the
ones actually carried out)
Parents’ preference: No Tests Doesn’t want
(studies consented to) Tests done to choose
All 29 6 2
Age
3-5 months 3 2 1
6-12 months 14 1 0
13-36 months 12 3 1
Sex
Male 16 4 2
Female 13 2 0
Parent
Mother 16 4 2
Father 1 1 0
Both 12 1 0
Age24 13 1 0
Age25 16 5 2
Medical Insurance
Private 13 3 1
Medicaid 15 2 0
None 1 1 1
Doctors recommendation
No tests recommended 2 0 1
Tests recommended 1 2 0
No recommendation 26 4 1
Max temperature
38.9to39.9 16 4 1
40.0 to 42.0 13 2 1
Otitis Media
Present 16 4 2
Not present 13 2 0
Seizure
Present 3 2 0
Not present 26 4 2
are too small to come to any conclusion.
Table 3 stratifies the parental antibiotic choices by demographic
and clinical variables. In three cases, parents declined to make an
antibiotic choice. In two of these cases (with otitis media), oral
antibiotics were prescribed. In the third case, no antibiotics were
prescribed.
There was a physician antibiotic recommendation in 31 of 37
cases (no antibiotics in 1, oral antibiotics in 28, and parenteral
antibiotics in 2). Antibiotics were recommended by the physician in
all 22 cases in which otitis media with effusion was diagnosed.
Parents followed the physician’s recommendation in most in
stances. However, in 8 instances, parents chose parenteral antibiot
ics when the physician recommended oral antibiotics. In one in
stance, parents chose no antibiotics when the physician recom
mended oral antibiotics. In one instance, parents chose oral antibi
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office. All patients were informed to return to the ED. if their
condition worsened. No patient returned to the E.D. for a follow-up
visit or to the hospital for hospitalization.
otics when the physician recommended parenteral antibiotics.
Parents of 34 of the 37 children indicated that they liked helping
the physician decide the treatment for their child. In two cases,
parents indicated that they did not like helping the physician decide
the treatment for their child. In one instance, a parent could not
decide.
Temperatures at discharge declined in 31 of 37 patients compared
to their admission temperature. Discharge temperatures were not
obtained in two patients who presented with admission E.D. tem
peratures of 38 degrees or less rectally (fever documented at home).
The temperature in one child did not decline. Discharge tempera
tures in the other three patients were not recorded on the charts. It
is possible that the discharge temperatures were not obtained, or
they were obtained, but not recorded.
All blood cultures obtained (five) were negative. Follow-up was
arranged for all patients in a clinic or their primary care physician’s
Discussion
The possibility that the wording of the information sheet used in
this survey may be biasing the decisions of parents is acknowl
edged25 The information sheet was written to remain as neutral as
possible. Yet the infomation sheet had to be simple and short. It
would be impossible to write an information sheet that is simple,
short, and perfectly accurate while satisfying all experts that its
wording is perfectly neutral. This less than perfectly accurate and
less than perfectly neutral information sheet was adopted realizing
its limitations.
It is likely that the preference choices made by parents were
substantially influenced by the recommendation of the treating
physician. However, the noted trend is that most parents chose no
tests in the absence of a physician’s recommendation. While most
parents followed the physician’s antibiotic treatment recommenda
tion, some parents chose more aggressive antibiotic treatment
options (parenteral) than the physician’s recommendation (oral).
The high number of antibiotic recommendations by the physician
makes it difficult to determine what the true antibiotic preferences
of the parents were. However, many children in this cohort were
diagnosed with otitis media with effusion and the risk factors ofeach
individual case had to be weighed by the physician making the
individual treatment recommendation to fit the ethical standard of
what was felt to be best for the individual child.
While the informed consent information disclosed during this
survey was largely limited to that listed in appendix A for most
cases, some parents asked for more details regarding specific
aspects of their child’s condition. The following issues were dis
closed in lay terms on an as needed basis. It is obvious, that the
disclosure of all these details would not be possible during a single
patient encounter.
The frequency of otitis media with effusion2627 in this group of
patients was high. In all instances, the severity of the otitis media
was felt to be low (otitis media with effusion as opposed to acute
otitis media).26’7 Parents were informed of this and in every case,
they were informed that such mild otitis media does not reliably
account for the fever28’9and their child’s risk for bacteremia and its
complications are no different than a child without otitis media.3°In
patients with otitis media, empiric antibiotics were recommended
whether or not blood cultures were obtained. The high frequency of
otitis media with effusion accounts for most ofthe empiric antibiotic
recommendations without obtaining a blood culture. Yet in one case
of otitis media with effusion, parents declined antibiotics when they
were informed that the likelihood of recovery following a course of
antibiotics was only slightly better than the likelihood of spontane
ous recovery26’7334(all parents of children with otitis media were
advised of this).
While patients with otitis media may be considered by some to be
a “source” of fever, it is often considered to be a source that is not
clinically useful in modifying risk since otitis media is associated
with a similar risk of bacteremia compared to febrile children
without otitis media.3°Fever without a source can be defined as an
instance in which the etiology of the fever is not apparent after a
careful history and physical examination.10In most instances, it is
Table 3.—Parents antibiotic (Abx) preferences (the actual treatments
carried out)
Parents’ preference: No Oral Parenteral Doesn’t want
(treatment consented to) Abx Abx +PO Abx to choose
All 4 20 10 3
Age
3-5 months 1 2 3 0
6-12 months 3 6 5 1
13-36 months 0 12 2 2
Sex
Male 3 11 6 2
Female 1 9 4 1
Medical insurance
Private 2 10 4 2
Medicaid 2 9 5 0
None 0 1 1 1
Tests done
(parents’ preference)
Notests 3 19 6 1
Tests done 1 1 3 1
Doesn’t want to choose 0 0 1 1
Physician’s antibiotic
recommendation
No recommendation 2 2 1 1
No antibiotics 1 0 0 0
Oral antibiotics 1 17 8 2
Parenteral antibiotics 0 1 1 0
Max temperature
38.9to39.9 3 11 5 2
40.0to42.0 1 9 5 1
Otitis Media
Present 1 13 6 2
Not present 3 7 4 1
Seizure
Present 0 4 0 1
Not present 4 16 10 2
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Information: Tests and Treatment For Children
With Fever Physician’ s Name, MD, Pediatrician
The doctor has examined your child and has found that the cause of
your child’s fever is probably not serious, Most of the fever is most
likely caused by a virus (like the flu virus). Antibiotics will not help your
child get rid of the virus. Since no doctor can be absolutely sure that this
fever is only caused by a virus, we must discuss some other possibilities
with you.
get worse and spread infection to the blood and brain. Children with
kidney infections often have abnormal kidneys. We won’t know about
this since you can’t feel the kidneys. You can only see them with special
X-rays with X-ray dye. To check for urine or kidney infection, we need
a sample of urine. We can’t ask small children to urinate in a cup so for
small children, we get a urine sample by putting a tube in the bladder to
let some urine out. Your child won’t like this, but it is quick and it won’t
cause any harm. Sometimes there is some bleeding from this, but this
will go away on its own.
3. Meningitis (infection in the brain). There are many types of
meningitis. Some meningitis is not too bad, but the bad form of
meningitis can kill you or cause permanent brain damange unless it is
treated early. Children with meningitis usually look very, very sick.
They usually have vomiting, a stiff neck, a bulging soft spot, or a bad
headache. They are usually fussy, drowsy, or don’t look at you well.
Since they have a bad headache, this gets worse if you bounce them
while carrying (they get more fussy if you do this) or if they jump up and
down. A spinal tap is needed to find meningitis. A spinal tap is painful,
but it is usually quick (1 to 3 minutes), and it will not harm your child.
4. Pneumonia (lung infection). Most pneumonias are not serious if
your child’s oxygen level is normal (we measured this with the red
light). To find out if your child has pneumonia, we need to do a chest
X-ray. X-rays can be harmful, but the dose of X-rays in a chest X-ray
is very small. Doctors believe this to be very safe.
1. Bacteria in the blood (bacteremia). There is roughly a 2% to 10%
chance that your child may have bacteria in the bloodstream. This is not
necessarily bad. Children with bacteria in the bloodstream will cure
themselves most of the time (even without antibiotics). However, about
1% to 5% of the time, a child may get a complication from this (such as
one of the infections below). To find out if your child has bacteria in the
bloodstream, we must draw a blood sample and grow this sample in the
lab for 2 days to see if any bacteria will grow out. We will not be able
to find out today ifyour child has bacteria in the bloodstream. It will take
2 days. We could do a blood count test today to find out if your child is
at high risk or low risk of bacteria in the bloodstream, but this test is not
always accurate. Many children with bacteria in the bloodstream have
normal blood counts and many children with abnormal blood counts do
not have bacteria in the bloodstream. If we give your child some
antibiotics, this might lower the chance that your child will get worse if
your child has bacteria in the bloodstream. An antibiotic shot seems to
be better than antibiotics by mouth. If your child has had all his/her
immunizations (RIB vaccine), then his/her risk of complications from
bacteria in the blood is even lower.
2. Kidney infection. There is a small chance that your child might
have an infection in the urine or kidneys. Young children don’t usually
tellus that itburns when they urinate. Ifuntreated, a kidney infection can
Doctor’s Survey: Since your child has fever, you should know that
the tests and treatment for this are very controversial. If you ask 10
pediatricians what to do, you will get many different answers. Most
office or clinic pediatricians would not do any tests. Some would do
blood tests only. Some would do blood tests and a urine test. Other
doctors would do all the tests. We would like to give you some choices
on how to approach this.
Please understand that all of these tests are safe.
Appendix B - Tests and Treatment Selection
Sheet
Doing all these tests is the safest approach. On the other hand, we don’t
want to do any unnecessary tests.
The doctor
recommends:
Do you want us to treat your child with antibiotics?
D No antibiotics
Antibiotic shots (high dose) - treats some hidden infections, but
not guaranteed to prevent worsening
Antibiotics by mouth - might treat some hidden infections
L I don’t want to choose. I want the doctor’s Recommendation
If you would like us to do more tests or less tests than the doctor
recommends, please tell us and we can discuss this.
Check one:
I don’t like helping the doctor decide the treatment for my child.
J I like helping the doctor decide the treatment for my child.
Do you want us to do these tests?
I don’t want to choose, I want the doctor’s recommendation.
Yes L No Blood tests - checking for bacteria in the bloodstream
Yes No Urine test - checking for urine or kidney infection
Yes No Spinal tap - checking for meningitis (brain infection)
D Yes No Chest X-ray - checking for pneumonia (lung infection)
You are child’s: Mother LI Father LI Other
How old are you?
I understand that doctors do not agree on which tests should be done
for fever.
I understand that the doctor has offered me all of these choices.
I understand that no choice is guaranteed to be perfect.
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child’s temperature decreased. Parents were in
formed that such a favorable temperature re
sponse to antipyretics does not rule out the
possibility of serious infection.3541 Similarly, a
clinical observation scale was not found to be
useful in detecting bacteremia.42Despite these
limitations, documentation of the child’s vital
signs and general appearance at discharge, if all
favorable, are added evidence to support a be
nign clinical assessment. It is common for an
hour to elapse following an admission dose of
antipyretics because ofpatient registration, phy
sician availability, review of the necessary in
formation, family discussion, charting, discharge
instructions, etc. Even in cases where antipyretics
were given late in the ED. visit, or the duration
of the E.D. visit was briefer than usual, all parents were willing to
stay in the E.D. for up to 45 minutes for a period of observation and
follow-up vital signs and clinical assessments.
Parents were informed that “expert” recommendations vary. This
listing in table 1 is not meant to be complete, but rather to illustrate
the spectrum of recommendations (for a more complete reference
list, refer to Singer, et alt9). Note that most of these reports are not
publishing recommendations based on newly acquired data, but
rather rely on data collected in the past. The two recent studies of
children (Basst2 and Fleishert4)both focused on comparing oral
antibiotics with parenteral antibiotics. Given the widespread use of
not convincing that otitis media is the source of a high fever28’9and
bacteremia risk is not altered by the presence of otitis media.3°
Additionally, otitis media is poorly defined and it ranges from
minimal to severe without an objective standardized severity scale.26’7
Otitis media results in fever in roughly 50% of cases.28’9 Febrile
children with otitis media often have a concurrent viral infection28’9
(and occasionally bacteremia30)which may be the actual cause of
the fever rather than the otitis media itself. Because otitis media
cannot be reliably considered to be the source of a fever, these
children should be considered at similar risk for bacteremia.
Anecdotally, parents seemed to feel some relief when their
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H. influenzae B vaccine in infants, it is likely that the most virulent
of the common bacteremial organisms is likely to be less prevalent
if a study of bacteremia were to be repeated today. Thus, the
conclusions reached by even the most recent of studies available to
us may only have limited applicability to the contemporary cohort
of children. The likelihood of a bad outcome is likely to be lower
currently, than it has been in the past)8
Although empiric antibiotics are often administered without
obtaining a blood culture, this choice receives negative reviews
from most experts, because it does not permit clinicians to identify
patients with bacteremia.8”It may also mask other existing infec
tions such as meningitis and urinary tract infections. The magnitude
of this potential problem is difficult to measure. In discussions with
parents, this issue does not appear to concern them as much as other
issues. In fact, the most frequent diagnostic/therapeutic choice was
that of no tests with oral antibiotics (most of these cases had otitis
media). It should be noted that:
1. The practice of administering a 10-day course oforal antibiotics
without a blood culture is done very frequently in offices and
emergency departments in the routine treatment of fever associated
with otitis media. The frequency of bacteremia and its complica
tions in children with otitis media is argued to be roughly similar to
that of similar children without otitis media.’4’3°The number of
these febrile children who are not cultured probably greatly out
numbers patients in the E.D. identified as at risk for occult bacter
emia. Yet there has been no substantial published concern recom
mending blood and/or urine cultures for febrile children prior to
antibiotic treatment for otitis media.
2. Despite obtaining a blood culture, the decision of whether to
hospitalize a patient with pneumococcal bacteremia is based on the
patient’s clinical status (persistent fever vs. afebrile and well-
appearing) at the time of the positive blood culture (ito 3 days later)
and not solely on the blood culture (unless it is positive for a more
virulent organism).8’9Thus, regardless of the blood culture results
(positive, negative, or not obtained) and regardless of whether a
patient is on antibiotics at the time of follow-up, patients who are not
doing well, should be investigated and treated more aggressively.8’9
This small survey of patients and parents described in this report
demonstrates that most parents are willing to digest substantial
amounts of medical information in a reasonably short period of
time. The degree to which they understand this information was not
measured in this survey. In the typical patient encounter, compre
hension cannot always be objectively and accurately assessed.
Clinicians must generally rely on communication skills and feed
back from the patient/parents to assess comprehension. In this
survey, once parents received the information, nearly everyone was
willing to express a preference and in most instances, their prefer
ence was not in favor ofperforming tests. Nearly everyone preferred
to participate in the medical decision making involving their child.
While this process was extremely time-consuming for the clinician
and possible only during periods of low ED. census, most parents
seemed to appreciate the information and time spent.
Since the diagnostic and therapeutic decisions involved in the
febrile child at risk for occult bacteremia are controversial, it is
difficult to say with certainty that any given approach is scientifi
cally superior to all other approaches. Despite the lack of scientific
certainty, practice guidelines have been published.8’9Practicing
pediatricians do not appear to consistently follow these guide-
lines23’4 and thus, the controversy has not ended.4345 While physi
cians may often feel the need to obtain a blood culture and admin
isterceftriaxone to febrile children who do not appear ill, would they
take this same approach for their own son or daughter? One study
indicates that they would not follow the practice guidelines for their
own child.46 Regardless, this choice, which is available to physi
cians, may not be offered to other patients if the practice guideline
recommendations are imposed upon patients without disclosure of
alternatives. Informed consent contemplates that patients should
collaborate with physicians in developing and evaluating treatment
options, with patients having a veto over any proposed treatment.2
Similarly in this report, parents were given information on the
issue of febrile children (without a source). Informed consent
should disclose to patients all information “material” to making a
decision whether to undergo or forgo a proposed treatment or
diagnostic procedure.”2This would include the disclosure of risks,
benefits, and alternatives.”
Medical legal liability concerns with informed consent raise
additional controversy.6Are parents capable of making informed
consent decisions? Will physicians be held liable if physicians
comply with parents’ preferences? Does involving the parents in the
decision making process result in more liability risk or less liability
risk?
The above questions are difficult to answer and these issues are
beyond the scope of this report. However, if the choice is to disclose
or withhold information about alternative approaches (discussion of
the range of diagnostic and therapeutic strategies), the doctrine of
informed consent states that we must not withhold the information,
regardless of what one’s opinion of the medical legal liability
consequences is.2While this may be ideal from an informed consent
perspective, most practicing physicians find this to be extremely
time consuming and often not possible in their practice.
A general principle of reducing malpractice risk is to disclose and
acknowledge the presence of uncertainty with patients. While
physicians prefer to form clear and accurate diagnoses and treat
ment plans for their patients, uncertainty exists.47 It should be
accepted by and acknowledged by the physician and the patient.
Disclosing the issues of controversy acknowledges this uncer
tainty.47When uncertainty presents choices, people make decisions
appropriate to a level of risk that they can tolerate. The “process
model” of informed consent (where patient and physician interact in
an ongoing relationship sharing information, clinical results, diag
nostic/therapeutic choices/recommendations, and personal/cultural
perferences2)provides an opportunity to establish a therapeutic
alliance between physician, patient, and family48 where the physi
cian, patient, and family are all co-active in sharing responsibility49
and hence, risk. Many health care risk managers agree that such a
process might reduce malpractice risk.48
In this survey, patients weighed the potential harm and discomfort
to their child from tests and treatments against the potential benefit
of the same. Since the tests and treatments are largely harmless, the
dominant negative factor remaining is pain sustained by their child.
Thus, most parents did not perceive the benefits of blood culture to
outweigh the pain consequence. The practice guidelines recom
mending blood work on all these patients8’9would suggest that the
wisdom of experts should outweigh the wisdom of parents. The
monetary cost of the tests was never considered by patients in this
survey. Nearly all the patients were insured and their out of pocket
HAWAII MEDICAL JOURNAL, VOL 56, NOVEMBER 1997
321
expenses for a CBC and blood culture would range from zero in
most instances to up to 20% of the insurance carrier’s pre-negotiated
preferred laboratory rates. Thus, most parents declined the tests
even if their out of pocket expenses were zero or a minimal cost.
These results are consistent with those found in a focus group of
33 parents choosing treatment options for a hypothetical 6-week old
infant with fever, in which parents tended to choose options that
involved less testing and more risk.20 Another study demonstrated
that parents and physicians differ in the way they value the benefits
and consequences of the tests, treatments, and outcomes of children
at risk of bacteremia.5°Parents emphasize the short-term pain,
discomfort, and inconvenience of the tests and are more willing to
risk rare but severe long-term morbidity to avoid the short-term
consequences of testing.5°These factors account for the findings of
our survey.
While physicians may find it less time consuming (and often
preferable) to impose their diagnostic and therapeutic plans upon
patients, informed consent requires that we spend more time with
patients discussing significant alternatives. This report shows that
this can be done even in a complex and controversial clinical
decision making scenario such as this. This process, however, is
very time consuming. A standardized information sheet reviewed
by a nurse may be a more efficient way of insuring informed
consent. This process would be similar to condition specific dis
charge information sheets that are reviewed with patients by nurses
or physicians at discharge. Such condition specific information
sheets can be composed for other conditions where decision making
is complex and controversial to optimize and document the process
of informed consent.
In summary, favorable points of informed consent are presented
where risks, benefits, and alternatives are disclosed. From the data
presented, we can conclude the following: 1) Parents overwhelm
ingly prefer to be included in the medical decisions affecting their
child. 2) Under the circumstances of this study, most parents were
not in favor of obtaining CBC’s and/or blood cultures. 3) No
conclusion can be drawn regarding the empiric antibiotic prefer
ences ofparents since antibiotics were recommended by the treating
physician in most instances. 4) The process of informed consent is
time consuming and often not possible when the E.D. is busy.
Physicians may find it desirable to make decisions from an informed
consent perspective to a comfort level dependent on time availabil
ity, parents’ comprehension ability, and individual personal prac
tice preference.
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